Literature DB >> 22749225

Prediction of in vitro fertilization outcome at different antral follicle count thresholds in a prospective cohort of 1,012 women.

Kannamannadiar Jayaprakasan1, Yeeyin Chan, Rumana Islam, Zeina Haoula, James Hopkisson, Arri Coomarasamy, Nick Raine-Fenning.   

Abstract

OBJECTIVE: To estimate the probability of live birth, adverse treatment outcome, and extremes of ovarian response at different antral follicle count (AFC) cutoff levels in a large prospective cohort of women undergoing IVF treatment.
DESIGN: Prospective study.
SETTING: University-based assisted conception unit. PATIENT(S): A total of 1,012 consecutive subjects of all ages undergoing their first cycle of assisted reproductive techniques. INTERVENTION(S): Transvaginal three-dimensional ultrasound assessment and venipuncture in the early follicular phase of the menstrual cycle. MAIN OUTCOME MEASURE(S): Live birth rate, poor ovarian response, and ovarian hyperstimulation syndrome (OHSS). RESULT(S): Analysis was performed in 1,012 subjects. Both age (r = 0.88) and AFC (r = 0.92) thresholds show significant linear relationship with the probability of live birth, but AFC demonstrates a stronger correlation. At AFC quartiles of 3-10, 11-15, 16-22, and ≥23, the mean live birth rates were 23%, 34%, 39%, and 44%, respectively. No live birth was observed in women with AFC <4. Antral follicle count was predictive of ovarian response, with a 67% likelihood of poor ovarian response for AFC ≤4. Although the risk of moderate or severe OHSS is 2.2% with AFC of ≤24, the risk increases to 8.6% at AFC of ≥24. The risk of OHSS increases further to 11% if there are signs and symptoms of polycystic ovary syndrome. CONCLUSION(S): Although age and AFC are significantly correlated with live birth, AFC demonstrates a stronger correlation. Antral follicle count thresholds are useful to predict live birth rates and risks of poor ovarian response and OHSS during IVF treatment.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22749225     DOI: 10.1016/j.fertnstert.2012.05.042

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  21 in total

1.  Reproductive endocrinology: Menstrual dysfunction--a proxy for insulin resistance in PCOS?

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2013-11-26       Impact factor: 43.330

Review 2.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

3.  The impact of polycystic ovary syndrome and body mass index on the absorption of recombinant human follicle stimulating hormone.

Authors:  Malinda S Lee; Andrea Lanes; Andrey V Dolinko; Alexandra Bailin; Elizabeth Ginsburg
Journal:  J Assist Reprod Genet       Date:  2020-07-04       Impact factor: 3.412

Review 4.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

Review 5.  Myostatin: a multifunctional role in human female reproduction and fertility - a short review.

Authors:  Sijia Wang; Lanlan Fang; Luping Cong; Jacqueline Pui Wah Chung; Tin Chiu Li; David Yiu Leung Chan
Journal:  Reprod Biol Endocrinol       Date:  2022-07-02       Impact factor: 4.982

6.  Evaluation of ovarian reserve in infertile patients.

Authors:  Mehmet Fırat Mutlu; Ahmet Erdem
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

7.  Outcomes of ovarian stimulation and fertility preservation in breast cancer patients with different hormonal receptor profiles.

Authors:  Jacques Balayla; Togas Tulandi; William Buckett; Hananel Holzer; Naama Steiner; Guy Shrem; Alexander Volodarsky-Perel
Journal:  J Assist Reprod Genet       Date:  2020-03-06       Impact factor: 3.412

8.  Measurement of antral follicle count in patients undergoing in vitro fertilization treatment: results of a worldwide web-based survey.

Authors:  Mindy S Christianson; Gon Shoham; Kyle J Tobler; Yulian Zhao; Christina N Cordeiro; Milton Leong; Zeev Shoham
Journal:  J Assist Reprod Genet       Date:  2015-09-04       Impact factor: 3.412

Review 9.  Deficiencies in reporting results of lesbians and gays after donor intrauterine insemination and assisted reproductive technology treatments: a review of the first emerging studies.

Authors:  Juan J Tarín; Miguel A García-Pérez; Antonio Cano
Journal:  Reprod Biol Endocrinol       Date:  2015-05-29       Impact factor: 5.211

10.  Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.

Authors:  Ali Abbara; Channa N Jayasena; Georgios Christopoulos; Shakunthala Narayanaswamy; Chioma Izzi-Engbeaya; Gurjinder M K Nijher; Alexander N Comninos; Deborah Peters; Adam Buckley; Risheka Ratnasabapathy; Julia K Prague; Rehan Salim; Stuart A Lavery; Stephen R Bloom; Matyas Szigeti; Deborah A Ashby; Geoffrey H Trew; Waljit S Dhillo
Journal:  J Clin Endocrinol Metab       Date:  2015-07-20       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.